In 2013 the company expects to treat more than 5,000 additional patients. Surgeons have treated several types of patients, including U.S. Army soldiers and professional athletes with iFuse.
Clinical publications show that the SI joint is a pain generator for up to 22 percent of low back pain patients.
More Articles on Spine Devices:
TranS1 Reports 32% Fall in 3Q Revenue
Titan Spine Appoints Marcus Klarl Vice President of Sales
LDR Receives Approvable Letter From FDA for Mobi-C Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
